Amr Radwan
5PUBLICATIONS
31CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Feb 05, 2025
Dupilumab is efficacious for eosinophilic esophagitis irrespective of prior swallowed budesonide or fluticasone, or prior treatments used alongside swallowed topical corticosteroids: results from the phase 3, randomized, placebo-controlled, LIBERTY EoE TREET trial.Albert J Bredenoord, Evan S Dellon, Christoph Schlag
|Feb 01, 2024
Long-Term Dupilumab Efficacy on Severe Exacerbations and Lung Function in Patients with Type 2 Asthma.Alberto Papi, Mario Castro, William W Busse
|Jan 22, 2024
Dupilumab Reduces Asthma Disease Burden and Recurrent SCS Use in Patients with CRSwNP and Coexisting Asthma.Mark Gurnell, Amr Radwan, Claus Bachert
|Dec 29, 2023
Impact of Dupilumab on Sinonasal Symptoms and Outcomes in Severe Chronic Rhinosinusitis With Nasal Polyps.Claire Hopkins, Joaquim Mullol, Asif H Khan
|Jul 11, 2023
Dupilumab sustains efficacy in patients with moderate-to-severe type 2 asthma regardless of inhaled corticosteroids dose.Ian D Pavord, Arnaud Bourdin, Alberto Papi
Pageof 1
Frequent Collaborators
5 joint publications
Juby A Jacob-Nara
2 joint publications
Alberto Papi
2 joint publications
Nami Pandit-Abid
2 joint publications
Scott Nash
2 joint publications
Asif H Khan
1 joint publications
Ian D Pavord
1 joint publications
Arnaud Bourdin
1 joint publications
Sandy Durrani
1 joint publications
Jonathan Corren
1 joint publications
Arman Altincatal
